|4Jan 3, 1:09 PM ET

Danielsen Erik 4

4 · NYMOX PHARMACEUTICAL CORP · Filed Jan 3, 2019

Insider Transaction Report

Form 4
Period: 2018-12-21
Danielsen Erik
Chief Financial Officer
Transactions
  • Purchase

    common stock

    2018-12-21$1.35/sh+6,000$8,08520,900 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT